Simon Lowth, Finance DirectorLowth has experience of the gas and power industry and a background in engineering. He served as Interim Chief Executive at AstraZeneca in 2013 and CFO of AstraZeneca from 2007 to 2013, where he helped the company improve productivity, cash management, and capital allocation. This will no doubt benefit BG Group’s current priority of executing and creating value.
Group Finance Director
Himanshu Raja, CFO
Nick Luff, CFO
Steve Hare, CFO
Den Jones, Group Finance Director
Oliver Tant, CFO
Adam Walker, Group Finance Director
Doug Webb, CFO
Executive Director & CFO
Dunoyer was announced as Executive Director and CFO of AstraZeneca, taking responsibility for Finance and Investor Relations and AstraZeneca’s business in Japan. Dunoyer joined AstraZeneca in June 2013 as Executive Vice-President, Global Portfolio & Product Strategy from his role at GlaxoSmithKline Japan, where he was Global Head of Rare Diseases and Chairman.
Nick Read, Group CFO
Read was appointed Group CFO and a member of the Vodafone Group Board. Read has held a number of senior roles since joining Vodafone in 2001, including CFO, CCO and CEO of the UK operating company, Vodafone Limited. His most recent role was Regional CEO for Africa, Middle East and Asia Pacific. Prior to joining Vodafone, he held senior global finance positions with United Business Media and Federal Express Worldwide.
Paul Edgecliffe-Johnson, CFO Edgecliffe-Johnson was previously CFO of IHG’s Europe & Asia, Middle East & Africa regions.
Legal & General
Mark Gregory, Group CFO
Gregory was previously Financial Director - Retail.
Carol Fairweather, CFO
Fairweather was previously Senior Vice President - Group Finance.
Heidrick & Struggles
Russel Reynolds Associate
Spencer Stuart & Associates
The Zygos Partnership